athenahealth downgraded to Underperform from Perform at Oppenheimer Oppenheimer downgraded its rating on shares of athenahealth (ATHN) to Underperform from Perform citing valuation. Opco believes athenahealth's market share has only increased around 3 points since 2010 and it set a $140 price target for shares. athenahealth closed Friday down $5.84 to $185.16.
News For ATHN From The Last 14 Days
Check below for free stories on ATHN the last two weeks.